J. Guo

Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia.

N. Heisterkamp, J. Groffen, J. ten Hoeve, 1994, Blood.

BCR-ABL tyrosine kinase is autophosphorylated or transphosphorylates P160 BCR on tyrosine predominantly within the first BCR exon.

M. Campbell, B. Andersson, R. Arlinghaus, 1993, Oncogene.

A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia.

J. Melo, A. Reiter, N. Cross, 1996, Blood.

BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapy.

A. Deisseroth, S. Stass, M. Talpaz, 1994, Blood.

Inhibition of phosphorylation of p160 BCR within p210 BCR-ABL complexes during early stages of phorbol ester-induced differentiation of K562 cells.

M. Campbell, R. Arlinghaus, D. Lu, 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Comparison of bcr-abl protein expression and Philadelphia chromosome analyses in chronic myelogenous leukemia patients.

H. Kantarjian, A. Deisseroth, M. Talpaz, 1996, American journal of clinical pathology.

Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.

M. Campbell, S. Stass, R. Champlin, 1993, Hematologic pathology.